Skip to content

DATURA

Determination of Adequate TUberculosis Regimen in Adults and adolescents hospitalised with HIV-associated severe immune suppression – NCT04738812

DATURA
Menu

Primary menu

  • Home
  • About
    • More about DATURA
    • DATURA project governance
    • Work Packages
      • WP5 Training and capacity building
      • WP6 Communication, dissemination and policy
    • Funding
  • Partners
    • Clinical sites
      • Cambodia
      • Cameroon
      • Guinea
      • Mozambique
      • Uganda
      • Zambia
  • Participants
    • Bindiya Meggi
    • Boubacar Djelo Diallo
    • Charles Kouanfack
    • Conrad K. Muzoora
    • Didier Laureillard
    • Eric Dailly
    • Eric-Walter Pefura
    • François-Xavier Blanc
    • Jean-Pierre Molès
    • John Tembo
    • Kondwelani John Mateyo
    • Maryline Bonnet
    • Nicolas Nagot
    • Ricky Heggheim
    • Suilanji Sivile
    • Sven Gudmund Hindraker
    • For participants
      • Datura documents
  • Trial Info
    • Hypothesis, Objectives, Study Design
    • Inclusion / non-inclusion criteria
    • Treatment details
    • Adherence
    • Randomisation
    • About TB and HIV/AIDS
  • Resources
  • Contact

Newsletter for spring 2024

Posted on 08/07/2024 by rhe001

Please click on the post to find the latest newsletter of 2024.

This entry was posted in other by rhe001. Bookmark the permalink.

Post navigation

← Previous Previous post: All African trial sites have completed their first patient enrolment
Next → Next post: First joint Project Steering Committee and Data and Safety Monitoring Board Meeting in 7-9 July 2024.

Primary Sidebar Widget Area

DATURA – a clinical trial

DATURA addresses people who are co-infected with TB and HIV. It is a research project that aims to assess whether an intensified initial TB treatment could increase survival in hospitalised, HIV-infected adults and adolescents compared to the standard TB treatment regime.

DATURA is registered in ClinicalTrials.gov : NCT04738812

  • Learn more key facts about TB & HIV – 2 often inter-linked global health challenges 
  • Why is DATURA undertaking this research?
  • DATURA Work Packages

Who is who in DATURA?

  • List of participants by role in project
  • Clinical sites
  • Participants listed by Work Project
  • Partner Institutions

Governance meetings

  • Project Executive meeting: 1 meeting every 3 months. Next on December 20th, 2022
  • Project Steering Committee: 1 meeting per year. Next on November or December, 2022
  • Data and Safety Monitoring Board meeting: the first meeting after the start of inclusions will be on October 24th, 2022

 

Important DATURA dates:

  • Mozambique participated as a trial site by 2024, with first patient inclusion in February 15th, 2024
  • The European and Developing Countries Clinical Trials Partnership (EDCTP)signed the Grant 14 April 2020.
  • Official starting date of the project period is 1 May 2020. The project will last for 54 months from this date.
  • DATURA kick-off 14-15 Sept. 2020
  • First participant enrolled on April 21st, 2022.
  • All African sites recruiting by August 2022.
  • EDCTP grant extended for an additional 14 months until December 2025.

TB Day

24 March – mark your calendar!

HIV Day

1 December – mark your calendar!

Recent Posts

  • First joint Project Steering Committee and Data and Safety Monitoring Board Meeting in 7-9 July 2024.
  • Newsletter for spring 2024
  • All African trial sites have completed their first patient enrolment

Categories

  • EDCTP
  • Meetings
  • Mission
  • News
  • other
  • Participants
  • publications
Copyright © 2024 DATURA. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up